Thursday, July 01, 2021 12:27:22 PM
That aside, the average cost basis of ordinary, public shareholders is way north of ISPCs current share price
Unfortunately, whatever forces contributed to the rise in share price have stepped aside.
I cashed in 1/3 with the recent rise and my remaining shares average cost is right here in upper 6's (not calculating my earlier profits into my cost basis)
Im fine holding still and maybe addiing
Recent ISPC News
- iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
- iSpecimen Reports Full Year 2023 Results • GlobeNewswire Inc. • 03/14/2024 12:00:00 PM
- iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call • GlobeNewswire Inc. • 03/12/2024 11:07:37 PM
- iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024 • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 02:26:44 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/05/2024 02:24:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:09:04 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:10:16 PM
- iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research • GlobeNewswire Inc. • 01/23/2024 12:30:00 PM
- Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET • GlobeNewswire Inc. • 01/22/2024 09:15:00 PM
- iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024 • GlobeNewswire Inc. • 01/18/2024 01:11:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 09:15:19 PM
- iSpecimen Strengthens Global Oncology Biospecimen Offering • GlobeNewswire Inc. • 12/07/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 01:01:04 PM
- iSpecimen Reports Third Quarter 2023 Financial and Operating Results • GlobeNewswire Inc. • 11/02/2023 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 10:30:39 AM
- iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research • GlobeNewswire Inc. • 10/26/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 11:45:11 AM
- iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially • GlobeNewswire Inc. • 10/23/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 09:29:04 PM
- iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers • GlobeNewswire Inc. • 09/28/2023 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/15/2023 08:23:45 PM
- iSpecimen Expands Provider Network to Enhance Support for Women’s Health Research • GlobeNewswire Inc. • 09/13/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 08:16:48 PM
- iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability • GlobeNewswire Inc. • 09/06/2023 08:05:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM